Glyco-Immune Diagnostic Signatures and Therapeutic Targets of Mesothelioma

doi 10.21236/ada588354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

High-Dimensional Single-Cell Proteomics Analysis Identifies Immune Checkpoint Signatures and Therapeutic Targets in Ulcerative Colitis

European Journal of Immunology
AllergyImmunology
2019English

The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2019English

Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?

Mediators of Inflammation
ImmunologyCell Biology
2016English

MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2010English

The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer

Scientific Reports
Multidisciplinary
2018English

Circulating and Disseminated Tumor Cells: Diagnostic Tools and Therapeutic Targets in Motion

Oncotarget
Oncology
2016English

Novel B Cell Therapeutic Targets in Transplantation and Immune-Mediated Glomerular Diseases

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

P2.06-42 AXL, C-Met and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Targeted Desialylation Overcomes Glyco-Immune Checkpoints and Potentiates the Anticancer Immune Response in Vivo

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy